Autori: Purkalne Gunta
Naslov | FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article) |
Autori | Brodowicz Thomas Ciuleanu Tudor E Radosavljevic Davorin Z Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Messinger D Zielinski Christoph |
Info | ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777 |
Projekat | CECOG |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) (Meeting Abstract) |
Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 15, Suppl. S, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). (Meeting Abstract) |
Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank Magdolna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 4, Suppl. S, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Cetuximab Weekly (Q1W) Versus Every Two Weeks (Q2W) Plus Folfox4 as First-line Therapy in Patients (PTS) with Kras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) (Meeting Abstract) |
Autori | Ciuleanu Tudor E Nikolic Vladimir Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Kahan Zsuzsanna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
Info | ANNALS OF ONCOLOGY, (2011), vol. 22 br. , Suppl. Suppl. 5, str. v22-v22 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (Editorial Material) |
Autori | Elsakov Pavel Foretova Lenka Goetz Petr de Groot Johannes WB van der Graaf Winette TA Guler Gulnur Huebner Kay Haites Neva E Hamann Ute Ho Judy Imyanitov Evgeny N Irmejs Arvids Purkalne Gunta Bitina Marianna Gardovskis Andris Gardovskis Janis Kirova Youlia M Fourquet Alain Pierga Jean-Yves Stoppa-Lyonnet Dominique Larizza Lidia Lips Cornelis JM Loman Niklas Borg Ake Moller Pal Olsson Hakan Park Jae-Gahb Radulovic Sinisa S Brankovic-Magic Mirjana V Rajkumar Thangarajan Razis Evangelia Yannoukakos Drakoulis Schmitt Fernando Schmutzler Rita Simmonds Peter D Eccles Diana Smeltzer Jacob Silberstein Peter T Lynch Henry Weber Walter Willemse Pax HB Sijmons Rolf H Wysocki Piotr J Zajac Vladimir Shu Zheng |
Info | HEREDITY CANCER IN CLINICAL PRACTICE, (2007), vol. 5 br. 3, str. 119-143 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|